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Abstract A 34-year-old woman with a previous history
of severe headache (‘‘thunderclap’’) was admitted with a
diagnosis of aneurysmal subarachnoid hemorrhage (SAH).
The patient developed symptomatic vasospasm on day 5
that resolved rapidly after having increased arterial blood
pressure. She experienced also short-lasting excruciating
headache. On day 12, while velocities had normalised, as
revealed by transcranial Doppler (TCD), for more than
48 h, she developed aphasia and right hemiplegia associ-
ated with diffuse segmental vasospasm on the left middle
cerebral artery. Intra-arterial infusion of vasodilatory
agents was required. Recurrence of symptomatic vaso-
spasm was noted on day 25, with a great number of terri-
tories involved as shown in the cerebral angiogram. A
second intra-arterial treatment was needed. The patient
complained of multiple episodes of extremely severe
headache (‘‘thunderclap’’), with also transient dysarthria
and hemiparesia on day 30. She was discharged on day 38
after full recovery. The clinical and TCD/radiological
findings were consistent with a reversible cerebral vaso-
constriction syndrome overlapping SAH related symp-
tomatic vasospasm.
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Introduction
Reversible cerebral vasoconstriction syndrome (RCVS) is a
rare vasculopathy of unknown etiology [1, 2]. It was
mainly reported in young women with a history of severe
‘‘thunderclap’’ headache. The clinical picture may mimic
subarachnoid hemorrhage (SAH). In addition, unruptured
aneurysms have been reported in some patients with
RCVS, but not clear causal relationship has been docu-
mented [3–5]. We describe a case of aneurysmal SAH for
which the differential diagnosis has to be discussed
between RCVS and symptomatic vasospasm.
Case report
A 34-year-old woman developed acute-onset occipital
headache with loss of consciousness. She had a history of
episodic severe headache treated by nonsteroidal anti-
inflammatory drugs. There was no clear precipitating
factor. The headache was described as generalised and
bilateral. The pain was excruciating and lasted usually less
than 1 h, being sometimes accompanied by nausea and
vomiting.
On arrival, she had a GCS of 15, and also with a mild
hypo-esthesia in the left arm. The brain CT confirmed the
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diagnosis of SAH (Fisher 3 radiological score), with a focal
hematoma in the territory of the left anterior cerebral artery
(ACA), blood in the subarachnoid spaces of the left sylvian
fissure and into the occipital horn of the left lateral ventricle.
The cerebral angiography revealed four distinct aneurysms.
The ruptured aneurysm (8 mm 9 9 mm) was located on
the junction of the A1–A2 segments of the left ACA.
The three unruptured aneurysms were on the A1 segment of
the left ACA (1.5 mm diameter), on the A2 segment
(3 mm 9 2 mm) and at the origin of the posterior com-
municating artery. The clipping of the four aneurysms was
performed without peri-operative complications and after
extubation the patient presented only neck stiffness and
photophobia. She received oral nimodipine and continuous
infusion of magnesium sulphate. On day 5 from bleeding,
she was found drowsy, with a slurry speech, and a vaso-
spasm on the left middle cerebral artery (MCA) was sus-
pected on transcranial Doppler (TCD). Systolic arterial
pressure was increased to 150 mmHg by norepinephrine
infusion followed by rapid neurological improvement. She
complained on days 9 and 10 of acute-onset but short-
lasting excruciating headache. Norepinephrine infusion was
tapered down and stopped on day 12. Velocities normalised
on TCD performed on days 7 and 10. She was discharged
from ICU on day 12 with a normal neurological examina-
tion but was readmitted the same night with right hemi-
plegia and aphasia. The diffusion-weighted imaging (DWI)
during brain MR showed a limited hyperintense lesion in
the left cingulum. As the symptoms persisted after 12 h of
intensive treatment, rescue therapy with intra-arterial va-
sodilatory agents was considered. Nimodipine (3 mg over
20 min) was infused in loco (left MCA) during cerebral
angiography, followed by intravenous continuous infusion
of milrinone (0.75 lg/kg per min). There was a prompt
recovery of aphasia and a regression of the motor deficit in
the upper right limb. The patient was able to move the right
lower limb on day 16. Milrinone infusion was continued for
a period of 11 days, and during this treatment, norepi-
nephrine infusion had to be increased to 2 lg/kg per min to
obtain an arterial systolic blood pressure of 150 mmHg. The
evolution of the clinical course and of the TCD/radiological
investigations is summarised in Table 1. On day 25, the
patient became drowsy and complained again from severe
headache. Bilateral vasospasm was demonstrated by TCD
and angiography (Fig. 1a, b). Intra-arterial infusion of
milrinone (15 mg over 60 min, divided in two doses in both
MCA) was performed, and intravenous infusion was started
again as in the previous episode, for a total of 5 days
(together with high doses of norepinephrine). Symptoms
regressed, except for headache (multiple episodes every
day). Finally, on day 30, dysarthria and right hemiparesia
were transiently noted. Magnesium sulphate infusion and
norepinephrine (as a part of the triple H therapy) were
stopped on day 32. The patient was discharged from the
ICU on day 38 after a normal neurological examination but
with persisting high velocities at TCD examination of the
right MCA. The velocities normalised completely only on
day 43. The patient made a complete recovery (including
headache) at 3 months follow-up.
Discussion
The idiopathic RCVS is a disease with cerebral vasocon-
striction that is usually documented by CT or MR angi-
ography. The syndrome should be differentiated from other
identified causes of arterial narrowing including CNS
vasculitis, pheochromocytoma or the use of vasoactive
substances like cocaine [1, 2]. In some patients, the pres-
ence of an associated intracranial abnormality can be
demonstrated, as in our patient who had a ruptured aneu-
rysm leading to SAH.
Obviously, vasospasm, symptomatic or not, is a com-
mon complication following aneurysmal SAH. The pres-
ence of blood close to the site of the aneurysm locally
triggers the vasospasm. The maximal duration of vaso-
spasm, when installed, is usually 4 weeks. However, a
delayed recurrence of symptomatic vasospasm is infre-
quent. Also the clinical symptoms and the TCD and
radiological findings were unusual. Recurrent excruciating
headache (‘‘thunderclap’’) was the main clinical feature. It
lasted for approximately one hour and was poorly influ-
enced by major analgesics. It occurred several times during
the same journey and seemed to be partly correlated with
increased velocities on TCD examination. Cerebral angi-
ography demonstrated migrating segmental vasoconstric-
tion in different cerebral arteries.
We suspected that cerebral vasoconstriction could be
triggered by two different mechanisms and postulated that
the patient presented an overlap between RCVS and SAH-
related vasospasm.
It has been suggested that some factors known to be
involved in SAH-related vasospasm (catecholamines,
endothelin-1, serotonin, nitric oxide, and prostaglandins)
could play a similar role in the pathophysiology of vaso-
constriction in RCVS [1, 2].
SAH without intracranial aneurysm is not infrequently
encountered in RCVS, perhaps in up to one in four cases,
and typically overlies the lateral-superior cortical surface
[3–6]. In RCVS, SAH is usually minimal or moderate in
amount and should not be considered the cause of the
segmental vasoconstriction, which affects artery remote to
the site of bleeding. An association between RCVS and
unruptured intracranial aneurysm has also be reported [5].
By definition, RCVS usually shows diffuse areas of
multiple stenosis and dilatation involving intracranial
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Table 1 Clinical course, TCD and radiological findings, and therapy






D1 Headache, loss of
consciousness
Nimodipine
D2 (Clipping) Nimodipine, MgSO4
D3 Nimodipine, MgSO4
D4 130/111 Headache Nimodipine, MgSO4
D5 154/123 Headache Left MCA(P) Nimodipine, MgSO4, THT
D6 160/135 Nimodipine, MgSO4, THT
D7 105/88 Nimodipine, MgSO4, THT
D8 Nimodipine, MgSO4, THT
D9 Nimodipine, MgSO4, THT
D10 95/88 Nimodipine, MgSO4, THT
D11 Nimodipine, MgSO4
D12 Nimodipine, MgSO4
D13 174/109 Aphasia, right hemiplegia Left ACA(C), diffuse D on
left M1 and right M1–M2
Nimodipine, MgSO4, THT-IA
nimodipine, IV milrinone
D14 99/62 Right leg plegia Nimodipine, MgSO4, THT, milrinone
D15 92/63 Nimodipine, MgSO4, THT, milrinone
Motor recovery
D16 Nimodipine, MgSO4, THT, milrinone
D17 105/60 Nimodipine, MgSO4, THT, milrinone
D18 140/60 Headache Nimodipine, MgSO4, THT, milrinone
D19 145/88 Headache Nimodipine, MgSO4, THT, milrinone
D20 121/80 Nimodipine, MgSO4, THT, milrinone
D21 122/62 Nimodipine, MgSO4, THT, milrinone
D22 Nimodipine, MgSO4, THT, milrinone
D23 Nimodipine, MgSO4, THT, milrinone
D24 89/71 Nimodipine, MgSO4, THT
D25 150/220 Confusion, agitation,
headache ???
See Fig. 1 Nimodipine, MgSO4, THT-IA ? IV
milrinone
D26 109/165 Headache Nimodipine, MgSO4, THT, milrinone
D27 96/100 Headache Nimodipine, MgSO4, THT, milrinone
D28 78/130 Headache Nimodipine, MgSO4, THT, milrinone
D29 Nimodipine, MgSO4, THT, milrinone
D30 Transient dysarthria and
right hemiparesia
RP1, focal BT, segmental
left M1, right M1
Nimodipine, MgSO4, THT
D31 96/166 Nimodipine, MgSO4, THT






D38 87/145 Full recovery Nimodipine
TCD transcranial Doppler, left ACA left anterior cerebral artery, left MCA left middle cerebral artery, right MCA right middle cerebral artery,
LM1 segment M1 of left MCA, RM1–2 segments 1–2 of right MCA, RP1 segment P1 of the right posterior cerebral artery, BT basilar trunk,
P proximal, C complete, D distal, THT triple-H therapy, IA intra-arterial (in loco), IV intravenous
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arteries [1, 2, 6]. These abnormalities are reversible within
days to weeks. In SAH, vasospasm typically is not multi-
focal, affects one or two medium arteries, and peaks
between days 4 and 11.
The pharmacological treatment of SAH-related vaso-
spasm relies on the so-called ‘‘triple-H therapy’’ (hyper-
tension, hypervolemia, hemodilution), where hypertension
induced by norepinephrine may play a major role. It can
not be excluded that vasoactive substances like norepi-
nephrine may aggravate RCVS [6]. The place of ‘‘rescue’’
therapy with intra-arterial vasodilatory agents is not yet
defined [7].
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Fig. 1 Angio-CT, three-dimensional reconstruction, coronal view.
a Diffuse segmental stenosis of the proximal and distal (arrows) right
middle cerebral artery. Segmental stenosis of the distal (arrows) left
middle cerebral artery. b Diffuse narrowing (arrows) of the distal
basilar trunk, of both posterior cerebral arteries, and of both superior
and anterior cerebellar arteries
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